Noriaki Fukuhara Selected Research

Noriaki Fukuhara Research Topics

Disease

17	Neoplasms (Cancer) 11/2021 - 10/2009
13	Pituitary Neoplasms (Pituitary Adenoma) 08/2021 - 12/2011
9	Adenoma (Adenomas) 04/2020 - 03/2012
5	ACTH-Secreting Pituitary Adenoma 03/2022 - 10/2009
4	Pituitary ACTH Hypersecretion 03/2022 - 10/2009
4	Acromegaly 08/2021 - 10/2010
3	Insulin Resistance 11/2017 - 07/2013
2	Growth Hormone-Secreting Pituitary Adenoma 05/2016 - 10/2010
1	Hyperprolactinemia 08/2021
1	Hypopituitarism (Sheehan's Syndrome) 08/2021
1	Thyroiditis 04/2021
1	Thyrotoxicosis 04/2021
1	Autoimmune Hypophysitis 01/2021
1	Hemorrhage 01/2017
1	Hyperthyroidism 01/2015
1	Cysts 04/2014
1	Alopecia (Baldness) 09/2013
1	Diabetes Mellitus 07/2013
1	Ketosis 07/2013
1	Glioma (Gliomas) 03/2013
1	Disease Progression 05/2012
1	Glioblastoma (Glioblastoma Multiforme) 10/2009

Drug/Important Bio-Agent (IBA)

7	Growth Hormone (Somatotropin)IBA 08/2018 - 10/2010
4	Adrenocorticotropic Hormone (ACTH)FDA Link 08/2021 - 03/2013
3	Insulin-Like Growth Factor I (IGF-1)IBA 08/2021 - 05/2016
3	Transcription Factors (Transcription Factor)IBA 04/2020 - 12/2015
3	Glucose (Dextrose)FDA LinkGeneric 05/2016 - 12/2011
3	Temozolomide (Temodar)FDA LinkGeneric 02/2016 - 10/2009
2	Hydrocortisone (Cortisol)FDA LinkGeneric 08/2021 - 01/2015
2	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 04/2021 - 12/2014
2	Thyrotropin (Thyroid-Stimulating Hormone)FDA Link 04/2021 - 12/2014
2	AntibodiesIBA 01/2021 - 07/2013
2	Hormones (Hormone)IBA 08/2018 - 12/2015
2	Insulin (Novolin)FDA Link 08/2018 - 05/2016
2	Pro-Opiomelanocortin (Proopiomelanocortin)IBA 02/2016 - 12/2015
2	Alkylating AgentsIBA 02/2016 - 03/2013
2	MethyltransferasesIBA 03/2013 - 10/2009
2	ProlactinIBA 03/2013 - 09/2012
1	somatostatin receptor 5IBA 03/2022
1	Somatostatin Receptors (Somatostatin Receptor)IBA 03/2022
1	pasireotideIBA 03/2022
1	Testosterone (Sustanon)FDA Link 08/2021
1	CateninsIBA 06/2021
1	Thyroid HormonesIBA 04/2021
1	B7-H1 AntigenIBA 04/2020
1	MutS ProteinsIBA 04/2020
1	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 05/2016
1	Ubiquitin-Specific ProteasesIBA 02/2016
1	Pharmaceutical PreparationsIBA 02/2016
1	Estrogen ReceptorsIBA 12/2015
1	Messenger RNA (mRNA)IBA 12/2015
1	Mucin-1 (CA 15-3 Antigen)IBA 07/2015
1	Phenobarbital (Luminal)FDA Link 07/2015
1	CAM 5.2 antigenIBA 07/2015
1	Corticotropin-Releasing HormoneIBA 01/2015
1	Octreotide (Sandostatin)FDA LinkGeneric 01/2015
1	SugarsIBA 07/2013
1	Anterior Pituitary HormonesIBA 03/2013
1	G-T mismatch-binding proteinIBA 03/2013
1	Capsules (Microcapsules)IBA 03/2012
1	Indicators and Reagents (Reagents)IBA 01/2012
1	Follicle Stimulating Hormone (Follitropin)FDA Link 12/2011
1	Arginine (L-Arginine)FDA Link 12/2011
1	O-(6)-methylguanineIBA 10/2009
1	DNA (Deoxyribonucleic Acid)IBA 10/2009

Therapy/Procedure

2	Radiotherapy 03/2022 - 10/2009
2	Therapeutics 03/2022 - 04/2021
2	Endoscopes 11/2021 - 04/2014
2	Adjuvant Radiotherapy 10/2017 - 05/2012
1	Hypophysectomy 03/2019
1	Craniotomy 01/2017
1	Subcutaneous Injections 01/2015
1	Duration of Therapy 01/2015
1	Neurosurgical Procedures 01/2015
1	Aftercare (After-Treatment) 12/2011